Compliance

Glaucoma 2017: Controlling IOP and Promoting Adherence through Novel Therapeutics

Glaucoma 2017: Controlling IOP and Promoting Adherence through Novel Therapeutics

Glaucoma is currently the second leading cause of blindness throughout the…

Expiration Date: 2/9/2018

Max Credits: 1

View Activity